Lilly completes biopharma acquisitions : comparemela.com

Eli Lilly and Company has completed acquisition of two biopharmaceutical companies – Versanis Bio and Sigilon Therapeutics - and their lead assets focused on obesity and diabetes.
Lilly announced...
-Today at 06:31 pm- MarketScreener

Related Keywords

China , United States , Canada , France , Japan , United Kingdom , Mt Cantor Fitzgerald , Ruth Gimeno , Aboutsurperformance Sasabout , Nederlands Nederland , M Eli Lilly , Europe America Asia , Mt Morgan Stanley , Versanis Bio , Deutsch Deutschland , Mt Goldman Sachs , Mt Eli Lilly , Deutsch Schweiz , Nederlands Belgi , Eli Lilly , Novo Nordisk , Eli Lilly And Company , B Other Pharmaceuticals , Company Profile Eli Lilly , Medicxi Ventures United Kingdom , Sony , Russell Publishing , Flagship Ventures Fund , Sector Pharmaceuticals Calendar , Company Durationauto , Versanis Bio Inc , First Trillion Dollar Healthcare Company Aug , Allianz , Sigilon Therapeutics Inc , Flagship Pioneering Special Opportunities Fund , Mt Wolfe Research Adjusts Eli Lilly Price , Company Trading Rating , Disney , Sector Other Pharmaceuticals , European Pharmaceutical , Russell Publishing Limited , Trade Journals Share , Eli Lilly Closes , Lilly Completes Purchase , Sigilon Therapeutics , Cash Deal , Lilly Completes Acquisition , Lilly Plans Over , Become First Trillion Dollar Healthcare Company , Medicxi Ventures , Down Weekly , Prices Moved Modestly Higher , Materials Weigh , Flagship Pioneering , Develop Diagnostics System , Identify Therapy Eligible Lung Cancer Patients , Lilly Gets Price Target Increases , Lilly Wraps Up Acquisition , Dice Therapeutics , Adjusts Eli Lilly Price Target , Maintains Overweight Rating , Fargo Adjusts Eli Lilly Price Target , Fitzgerald Adjusts Eli Lilly Price Target , Securities Adjusts Eli Lilly Price Target , Maintains Buy Rating , Suisse Adjusts Eli Lilly Price Target , Maintains Outperform Rating , Stanley Adjusts Eli Lilly Price Target , Research Adjusts Eli Lilly Price Target , Sachs Raises Eli Lilly Price Target , Maintains Neutral Rating , Max Perioddayweek , Company Profile , Income Statement Evolution , Trading Rating , Investor Rating , More Ratings , Analyst Consensus , Close Price , More Indexes , More Top , Virtual Portfoliosnewsletters , Markets ,